These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 27363651)
1. Protective effects of naringenin in cardiorenal syndrome. Liu Y; An W; Gao A J Surg Res; 2016 Jun; 203(2):416-23. PubMed ID: 27363651 [TBL] [Abstract][Full Text] [Related]
2. Apocynin Attenuates Cardiac Injury in Type 4 Cardiorenal Syndrome via Suppressing Cardiac Fibroblast Growth Factor-2 With Oxidative Stress Inhibition. Liu Y; Liu Y; Liu X; Chen J; Zhang K; Huang F; Wang JF; Tang W; Huang H J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26109504 [TBL] [Abstract][Full Text] [Related]
3. Protective effects of valsartan and benazepril combined with atorvastatin on cardiorenal syndrome in rats. Tang SY; Peng DF; Hu YJ; Chen J Eur Rev Med Pharmacol Sci; 2015; 19(5):759-66. PubMed ID: 25807427 [TBL] [Abstract][Full Text] [Related]
4. Qiliqiangxin Protects against Renal Injury in Rat with Cardiorenal Syndrome Type I through Regulating the Inflammatory and Oxidative Stress Signaling. Duan X; Yan F; Hu H; Liu H; Wu Q; Sun S; Ming X; Bu X; He Y; Zhu H Biol Pharm Bull; 2018; 41(8):1178-1185. PubMed ID: 30068867 [TBL] [Abstract][Full Text] [Related]
5. Entresto protected the cardiomyocytes and preserved heart function in cardiorenal syndrome rat fed with high-protein diet through regulating the oxidative stress and Mfn2-mediated mitochondrial functional integrity. Yeh JN; Yue Y; Chu YC; Huang CR; Yang CC; Chiang JY; Yip HK; Guo J Biomed Pharmacother; 2021 Dec; 144():112244. PubMed ID: 34601193 [TBL] [Abstract][Full Text] [Related]
6. Higenamine Improves Cardiac and Renal Fibrosis in Rats With Cardiorenal Syndrome via ASK1 Signaling Pathway. Deng T; Wei Z; Gael A; Deng X; Liu Y; Lai J; Hang L; Yan Q; Fu Q; Li Z J Cardiovasc Pharmacol; 2020 Jun; 75(6):535-544. PubMed ID: 32168151 [TBL] [Abstract][Full Text] [Related]
7. [The effect of nuclear factor erythroid-2-related factor2 on the changes of cardiac function and electrocardiogram in rats after exhausted exercise]. Xu P; Kang T; Liu HY; Sun WW; Xie YN; Cao XB Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2016 Feb; 32(2):146-151. PubMed ID: 29931867 [TBL] [Abstract][Full Text] [Related]
8. Naringenin protects against cadmium-induced oxidative renal dysfunction in rats. Renugadevi J; Prabu SM Toxicology; 2009 Feb; 256(1-2):128-34. PubMed ID: 19063931 [TBL] [Abstract][Full Text] [Related]
9. Subtotal nephrectomy accelerates pathological cardiac remodeling post-myocardial infarction: implications for cardiorenal syndrome. Liu S; Kompa AR; Kumfu S; Nishijima F; Kelly DJ; Krum H; Wang BH Int J Cardiol; 2013 Oct; 168(3):1866-80. PubMed ID: 23347614 [TBL] [Abstract][Full Text] [Related]
10. The cardioprotective effect of melatonin and exendin-4 treatment in a rat model of cardiorenal syndrome. Chua S; Lee FY; Chiang HJ; Chen KH; Lu HI; Chen YT; Yang CC; Lin KC; Chen YL; Kao GS; Chen CH; Chang HW; Yip HK J Pineal Res; 2016 Nov; 61(4):438-456. PubMed ID: 27465663 [TBL] [Abstract][Full Text] [Related]
11. Effects of Xin-Ji-Er-Kang formula on 2K1C-induced hypertension and cardiovascular remodeling in rats. Guo K; Lan CZ; Yu TT; Huang LL; Wang XH; Pan C; Gao S J Ethnopharmacol; 2014 Sep; 155(2):1227-35. PubMed ID: 25063306 [TBL] [Abstract][Full Text] [Related]
12. Amelioration of Benzo[a]pyrene-induced oxidative stress and pulmonary toxicity by Naringenin in Wistar rats: A plausible role of COX-2 and NF-κB. Ali R; Shahid A; Ali N; Hasan SK; Majed F; Sultana S Hum Exp Toxicol; 2017 Apr; 36(4):349-364. PubMed ID: 27206700 [TBL] [Abstract][Full Text] [Related]
14. The therapeutic impact of entresto on protecting against cardiorenal syndrome-associated renal damage in rats on high protein diet. Yang CC; Chen YT; Chen CH; Li YC; Shao PL; Huang TH; Chen YL; Sun CK; Yip HK Biomed Pharmacother; 2019 Aug; 116():108954. PubMed ID: 31108352 [TBL] [Abstract][Full Text] [Related]
15. Allicin ameliorates cardiac hypertrophy and fibrosis through enhancing of Nrf2 antioxidant signaling pathways. Li XH; Li CY; Xiang ZG; Hu JJ; Lu JM; Tian RB; Jia W Cardiovasc Drugs Ther; 2012 Dec; 26(6):457-65. PubMed ID: 22990325 [TBL] [Abstract][Full Text] [Related]
16. Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways. Li HL; Wang AB; Huang Y; Liu DP; Wei C; Williams GM; Zhang CN; Liu G; Liu YQ; Hao DL; Hui RT; Lin M; Liang CC Free Radic Biol Med; 2005 Jan; 38(2):243-57. PubMed ID: 15607907 [TBL] [Abstract][Full Text] [Related]
17. Role of Renal Oxidative Stress in the Pathogenesis of the Cardiorenal Syndrome. Giam B; Kaye DM; Rajapakse NW Heart Lung Circ; 2016 Aug; 25(8):874-80. PubMed ID: 27132623 [TBL] [Abstract][Full Text] [Related]
18. [Mechanism of cardiac function changes in rat models of Sjogren's syndrome based on Keap1-Nrf2/ARE signaling pathways]. Wang F; Liu J; Ye Y; Zhang X; Wan L Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 May; 30(5):497-501. PubMed ID: 24796746 [TBL] [Abstract][Full Text] [Related]
19. Valsartan attenuates cardiac and renal hypertrophy in rats with experimental cardiorenal syndrome possibly through down-regulating galectin-3 signaling. Zhang MJ; Gu Y; Wang H; Zhu PF; Liu XY; Wu J Eur Rev Med Pharmacol Sci; 2016; 20(2):345-54. PubMed ID: 26875907 [TBL] [Abstract][Full Text] [Related]
20. Polyphenol-Rich Fraction of Parquetina nigrescens Mitigates Dichlorvos-Induced Cardiorenal Dysfunction Through Reduction in Cardiac Nitrotyrosine and Renal p38 Expressions in Wistar Rats. Oyagbemi AA; Omobowale TO; Ochigbo GO; Asenuga ER; Ola-Davies OE; Ajibade TO; Saba AB; Adedapo AA J Diet Suppl; 2018 May; 15(3):269-284. PubMed ID: 28800275 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]